Rosetta Genomics First Quarter 2007 Financial Results Conference Call

    REHOVOT, Israel and NEW BRUNSWICK, N.J., May 1 /PRNewswire-FirstCall/
 -- Rosetta Genomics, Ltd. (Nasdaq:   ROSG) announced that the company will
 report first quarter 2007 financial results on Tuesday, May 8, 2007, after
 U.S. financial markets close. Following the announcement, senior management
 will host a conference call and webcast at 4:30 p.m. Eastern Time to
 discuss financial results and corporate highlights.
     To access the live conference on May 8 at 4:30 p.m. Eastern Time via
 phone, please dial (866)-409-1557 from the United States and Canada or
 1-(913)-312-1237 internationally. The conference passcode is 3026948.
 Please dial in approximately fifteen minutes prior to the start of the
 call. A telephone replay will be available beginning approximately one hour
 after the call through May 15 and may be accessed by dialing (888)-203-1112
 from the United States and Canada or 1-(719)-457-0820 internationally. The
 replay passcode is 3026948.
     To access the live and subsequently archived webcast of the conference
 call, go to the Investor Relations section of the Company's website at
 http://www.rosettagenomics.com. Please connect to the web site at least 15
 minutes prior to the call to allow for any software download that may be
 necessary.
     About Rosetta Genomics
     Rosetta Genomics (Nasdaq:   ROSG) is a leader in the development of
 microRNA-based diagnostics and therapeutics. The company's integrative
 research platform combining bioinformatics and state-of-the-art laboratory
 processes has led to the discovery of hundreds of biologically validated
 novel human microRNAs. Building on its strong IP position and strategic
 alliances with leading biotechnology companies, Rosetta Genomics is working
 to develop a full range of diagnostic and therapeutic products based on
 microRNAs. The company's primary focus is in the development of
 microRNA-based products to diagnose and treat different forms of cancer and
 infectious diseases.
     Media and Investors
     Ron Kamienchick, 972-8-948-4785
     Ron_ka@rosettagenomics.com
 
 

SOURCE Rosetta Genomics, Ltd.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.